Giulia Pellizzari

St. John's Institute Of Dermatology
London, ENG, United Kingdom

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 20 publications

Hyperinflammatory repolarisation of ovarian cancer patient macrophages by anti-tumour IgE antibody, MOv18, restricts an immunosuppressive macrophage:Treg cell interaction.

Hyperinflammatory repolarisation of ovarian cancer patient macrophages by anti-tumour IgE antibody, MOv18, restricts an immunosuppressive macrophage:Treg cell interaction.

Journal: Nature communications

Published: December 09, 2023

Closing the gaps in recruitment and retention in cancer trials: sufficient evidence but poor implementation.

Closing the gaps in recruitment and retention in cancer trials: sufficient evidence but poor implementation.

Journal: BMJ oncology

Published: November 20, 2023

Safety and anti-tumour activity of the IgE antibody MOv18 in patients with advanced solid tumours expressing folate receptor-alpha: a phase I trial.

Safety and anti-tumour activity of the IgE antibody MOv18 in patients with advanced solid tumours expressing folate receptor-alpha: a phase I trial.

Journal: Nature communications

Published: March 02, 2023

B cell profiles, antibody repertoire and reactivity reveal dysregulated responses with autoimmune features in melanoma.

B cell profiles, antibody repertoire and reactivity reveal dysregulated responses with autoimmune features in melanoma.

Journal: Nature communications

Published: June 01, 2022

Anti-cancer pro-inflammatory effects of an IgE antibody targeting the melanoma-associated antigen chondroitin sulfate proteoglycan 4.

Anti-cancer pro-inflammatory effects of an IgE antibody targeting the melanoma-associated antigen chondroitin sulfate proteoglycan 4.

Journal: Nature communications

Published: February 03, 2022

Immunotherapy using IgE or CAR T cells for cancers expressing the tumor antigen SLC3A2.

Immunotherapy using IgE or CAR T cells for cancers expressing the tumor antigen SLC3A2.

Journal: Journal for immunotherapy of cancer

Published: April 25, 2021

Basophils from Cancer Patients Respond to Immune Stimuli and Predict Clinical Outcome.

Basophils from Cancer Patients Respond to Immune Stimuli and Predict Clinical Outcome.

Journal: Cells

Published: June 17, 2020

In vivo safety profile of a CSPG4-directed IgE antibody in an immunocompetent rat model.

In vivo safety profile of a CSPG4-directed IgE antibody in an immunocompetent rat model.

Journal: mAbs

Published: November 27, 2019

Harnessing Therapeutic IgE Antibodies to Re-educate Macrophages against Cancer.

Harnessing Therapeutic IgE Antibodies to Re-educate Macrophages against Cancer.

Journal: Trends in molecular medicine

Published: October 31, 2019

Epinephrine drives human M2a allergic macrophages to a regulatory phenotype reducing mast cell degranulation in vitro.

Epinephrine drives human M2a allergic macrophages to a regulatory phenotype reducing mast cell degranulation in vitro.

Journal: Allergy

Published: September 30, 2019

Basophil activation test in cancer patient blood evaluating potential hypersensitivity to an anti-tumor IgE therapeutic candidate.

Basophil activation test in cancer patient blood evaluating potential hypersensitivity to an anti-tumor IgE therapeutic candidate.

Journal: Allergy

Published: September 26, 2019

IgE re-programs alternatively-activated human macrophages towards pro-inflammatory anti-tumoural states.

IgE re-programs alternatively-activated human macrophages towards pro-inflammatory anti-tumoural states.

Journal: EBioMedicine

Published: February 13, 2019

Showing 1-12 of 20

Last Updated: 09/26/2026